ADAR1 Capital Management »

Uniqure Nv shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Uniqure Nv (QURE) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Uniqure Nv

Tip: Access up to 7 years of quarterly data

All positions including Uniqure Nv held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Uniqure Nv by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 293k 5.20

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Uniqure Nv

Nantahala Capital Management
683 Capital Management
BlackRock
Morgan Stanley
Susquehanna International
Schroder Investment Management Group
Vanguard Group
Jpmorgan Chase & Co
D. E. Shaw & Co
Bnp Paribas Arbitrage, Snc
Ameriprise Financial
Macquarie Group
Citadel Advisors
Acadian Asset Management
Privium Fund Management B.V.

View all funds holding Uniqure Nv